Table 1. Breakpoints (µg/ml) Used for Susceptibility Testing of Salmonella and E.coli
| CLSI Subclass |
Antimicrobial |
Susceptible breakpoint |
Intermediate breakpoint |
Resistant breakpoint |
| Aminoglycosides |
Amikacin |
<=16 |
32 |
>=64 |
| Gentamicin |
<=4 |
8 |
>=16 |
| Kanamycin |
<=16 |
32 |
>=64 |
| Streptomycin |
<=32 |
N/A |
>=64 |
| Aminopenicillins |
Ampicillin |
<=8 |
16 |
>=32 |
| Beta-Lactam/Beta-Lactamase Inhibitor Combinations |
Amoxicillin/Clavulanic Acid |
<=8/4 |
16/8 |
>=32/16 |
| Cephalosporins I |
Cephalothin |
<=8 |
16 |
>=32 |
| Cephalosporins III |
Ceftiofur |
<=2 |
4 |
>=8 |
| Ceftriaxone |
<=8 |
16 and 32 |
>=64 |
| Cephamycins |
Cefoxitin |
<=8 |
16 |
>=32 |
| Folate Pathway Inhibitors |
Sulfanomides |
<=256 |
N/A |
>=512 |
| Trimethoprim/Sulfamethoxazole |
<=2/38 |
N/A |
>=4/76 |
| Phenicols |
Chloramphenicol |
<=8 |
16 |
>=32 |
| Fluoroquinolones |
Ciprofloxacin |
<=1 |
2 |
>=4 |
| Quinolones |
Nalidixic Acid |
<=16 |
N/A |
>=32 |
| Tetracyclines |
Tetracycline |
<=4 |
8 |
>=16 |
|
Table 1 notes:
Breakpoints established by CLSI (Clinical and Laboratory Standards Institute) were used when available
CLSI subclasses are in accordance with CLSI M100 document.
No CLSI breakpoints are available for streptomycin
N/A - Not applicable
Table 2. Breakpoints (µg/ml) Used for Susceptibility Testing of Campylobacter
| CLSI Subclass |
Antimicrobial |
Broth Microdilution Breakpoints (2005-2007) |
Etest Breakpoints (1998-2004) |
| Susceptible |
Intermediate |
Resistant |
Susceptible |
Intermediate |
Resistant |
| Aminoglycosides |
Gentamicin |
<=2 |
4 |
>=8 |
<=4 |
8 |
>=16 |
| Lincosamides |
Clindamycin |
<=2 |
4 |
>=8 |
<=0.5 |
1 and 2 |
>=4 |
| Macrolides |
Azithromycin |
<=2 |
4 |
>=8 |
<=0.25 |
0.5 and 1 |
>=2 |
| Erythromycin |
<=8 |
16 |
>=32 |
<=0.5 |
1 and 4 |
>=8 |
| Ketolides |
Telithromycin |
<=4 |
8 |
>=16 |
NT |
NT |
NT |
| Phenicols |
Florfenicol |
<=4 |
N/A |
N/A |
NT |
NT |
NT |
| Chloramphenicol |
NT |
NT |
NT |
><=8 |
16 |
>=32 |
| Fluoroquinolones |
Ciprofloxacin |
<=1 |
2 |
>=4 |
<=1 |
2 |
>=4 |
| Quinolones |
Nalidixic acid |
<=16 |
32 |
>=64 |
<=16 |
N/A |
>=32 |
| Tetracyclines |
Tetracycline |
<=4 |
8 |
>=16 |
<=4 |
8 |
>=16 |
Table 2 notes:
Breakpoints established by CLSI (Clinical and Laboratory Standards Institute) were used when available. CLSI breakpoints are available only for erythromycin, ciprofloxacin, and tetracycline
CLSI subclasses are in accordance with CLSI M100 document.
N/A - Not applicable
NT - Not tested